Condition

CMV Viremia

ClinicalTrials.gov condition label

Clinical trials3

Recruiting2

Common interventions3

Lead sponsors shown3

Clinical trials

3 shown

Trial to Study Anti- HCMV Therapy in Breast Cancer Patients With Progressive Intracranial Metastases and CMV InfectionNCT07383649 · 2026-07-14

RECRUITING

Valganciclovir vs. Letermovir for CMV Prophylaxis in Heart TransplantNCT07079735 · 2025-09-12

RECRUITING

Expanded Access Protocol of ATA230 (Third-Party Donor-Derived CMV-CTLs) for the Treatment of CMV Viremia or DiseaseNCT03010332

NO_LONGER_AVAILABLE

Common interventions

ValganciclovirDRUG2Cytomegalovirus-specific Cytotoxic T Lymphocytes (CMV-CTLs)BIOLOGICAL1LetermovirDRUG1

Leading sponsors

Atara Biotherapeutics1Columbia University1The Methodist Hospital Research Institute1

Trial status mix

RECRUITING2

NO_LONGER_AVAILABLE1

Phase mix

PHASE22

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.